AuntMinnie

MARCH 25, 2025

Eckert & Ziegler has entered into an agreement with Actinium Pharmaceuticals to supply the firm with the radioisotope actinium-225 (Ac-225). Actinium will continue developing its lead radiopharmaceutical product Actimab-A, as well as additional early and late-stage development candidates for both U.S. and international clinical trials.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Clinic IT 130

AuntMinnie

MARCH 14, 2025

Shuttle Pharmaceuticals Holdings has closed a previously announced underwritten public common stock offering, with aggregate gross proceeds of approximately $5.8 The Gaithersburg, MD-based specialty pharmaceutical company offered 19.1 million shares of its common stock at a public offering price of 30 per share.

Pharmaceutical 100

Pharmaceutical Clinic IT 100

Radiology Business

DECEMBER 18, 2023

Telix Pharmaceuticals recently submitted its license application to the FDA for the investigational positron emission tomography agent TLX250-CDx (Zircaix).

Pharmaceutical 290

Pharmaceutical Imaging IT 290

Health Imaging

OCTOBER 23, 2024

The facility will provide much needed developmental and manufacturing support for pharmaceutical companies that produce and distribute medical isotopes.

Pharmaceutical 259

Pharmaceutical Medical 259

Radiology Business

FEBRUARY 27, 2024

Progenics Pharmaceuticals Inc. claims MIM stole its patents and used them to help entice GE HealthCare to buy the company in January.

Pharmaceutical 278

Pharmaceutical Radiology Healthcare Healthcare 278

Radiology Business

SEPTEMBER 20, 2023

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

Nuclear Medicine 264

Nuclear Medicine Pharmaceutical Diagnostic Imaging Diagnostic 264

AuntMinnie

NOVEMBER 20, 2024

Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine.

Nuclear Medicine 130

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 130

AuntMinnie

JANUARY 13, 2025

Telix Pharmaceuticals has entered into an asset purchase agreement with ImaginAb initially worth $45 million. Under terms of the deal, Telix will acquire a pipeline of therapeutic candidates such as DLL3 and integrin v6, a biologics technology platform, and a protein engineering and discovery research facility in California, it said.

Pharmaceutical 130

Pharmaceutical IT 130

Imaging Technology

JANUARY 23, 2024

milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.

Pharmaceutical 105

Pharmaceutical Radiology Healthcare Healthcare 105

AuntMinnie

FEBRUARY 16, 2024

Fusion Pharmaceuticals announced a patent dispute settlement and new licensing agreement with Heidelberg University and Euratom for exclusive, worldwide rights to their existing patent for FPI-2265, an actinium-225-based targeted radiotherapy for the treatment of prostate-specific membrane antigen (PSMA)-expressing cancers.

Pharmaceutical 100

Pharmaceutical Radiopharmaceuticals Medical IT 100

Radiology Business

APRIL 17, 2023

For one pharmaceutical company, a plan to independently source barium and iodine from North America may offer protection from global supply chain disruptions.

Pharmaceutical 236

Pharmaceutical Imaging 236

AuntMinnie

MAY 28, 2024

Telix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for a new prostate-specific membrane antigen (PSMA)-PET cold kit for prostate cancer imaging.

Pharmaceutical 246

Pharmaceutical Imaging 246

AuntMinnie

JUNE 26, 2023

NorthStar Medical Radioisotopes is routinely manufacturing copper-67(Cu-67. Read more on AuntMinnie.com Related Reading: NorthStar appoints new president/CEO NorthStar installs accelerator at its new Wisc.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Medical IT 130

AuntMinnie

MARCH 7, 2025

The group analyzed flortaucipir (Tauvid, Avid Pharmaceuticals) PET scans acquired over a 3.5-year Moreover, currently, approximately a quarter of postmenopausal women who are 70 years and older have a history of HT use and have now entered a critical age of risk for Alzheimers disease, the authors added.

Disease 162

Disease PET Scan Pharmaceutical Education 162

Imaging Technology

SEPTEMBER 20, 2023

We designed RXM-4768 with the unique requirements for SCINTIX therapy in mind, and our preclinical data demonstrated its potential as an effective biology guide for potentially most solid tumor cancer types,” said Dr. Ulrich Reineke , founder & managing director of 3B Pharmaceuticals. “We

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 105

AuntMinnie

DECEMBER 3, 2023

Telix Pharmaceuticals is highlighting that the first patient has been dosed with the company's TLX250-CDx (Zr-89 DFO-girentuximab) for clear cell renal cell carcinoma, the most common and aggressive form of kidney cancer.

Pharmaceutical 244

Pharmaceutical Medical IT Radiology 244

AuntMinnie

JULY 23, 2024

Telix Pharmaceuticals said that the U.S.

Pharmaceutical 246

Pharmaceutical Imaging Healthcare Healthcare 246

AuntMinnie

MAY 1, 2024

NETTER-P was conducted as part of a pediatric Written Request under the Best Pharmaceuticals for Children Act, the FDA stated. The application was granted priority review and orphan drug designation. A postmarketing requirement was issued to assess the long-term safety of Lu-177 DOTATATE in adolescents.

Radiopharmaceuticals 240

Radiopharmaceuticals Pharmaceutical Radiology 240

MRI Network

JULY 19, 2024

It’s also primed to revolutionize the pharmaceutical industry. This is where MRI Network recruiters focused on the pharmaceutical industry come into play. Generative AI systems can also track company leadership and researchers responsible for key decisions from program initiation to completion.

Pharmaceutical 59

Pharmaceutical Disease MRI Clinic 59

AuntMinnie

OCTOBER 18, 2024

Australia-based Telix Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) to list its ordinary shares and trade on the Nasdaq under the ticker symbol “TLX.” Telix is not proposing to raise capital or issue any new shares, it said.

Pharmaceutical 246

Pharmaceutical IT Diagnostic Imaging 246

Radiology Business

AUGUST 26, 2024

The Swiss pharmaceutical firm operates Europe’s second largest network of cyclotrons, used to manufacture radioactive compounds needed for PET scans.

PET Scan 147

PET Scan Pharmaceutical Imaging 147

AuntMinnie

JULY 24, 2024

Produced by the ACR Committee on Drugs and Contrast Media, the new manual features four updates: An update and addition of Ferumoxytol as a new MRI contrast medium for Chapter 12 – Contrast Media in Children An update for Chapter 13 - Gastrointestinal (GI) Contrast Media in Adults: Indications and Guidelines An evidence-based update with recommendations (..)

Pharmaceutical 182

Pharmaceutical MRI Healthcare Healthcare 182

Keosys Medical Imaging

AUGUST 26, 2024

With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. Here is another excerpt from our conversation.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals 52

AuntMinnie

JUNE 10, 2024

Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. Prior to that, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. He was previously CFO and chief operating officer (COO) at Tyber Medical.

Pharmaceutical 130

Pharmaceutical Medical Device Ultrasound Medical 130

AuntMinnie

MAY 19, 2024

He will oversee Lantheus’ research and development organization, including research and pharmaceutical development, regulatory affairs, clinical development, medical affairs, and isotope strategy. He has spent more than two decades working for pharmaceutical companies such as Bayer, Bristol-Myers Squibb, Kyowa Kirin, and Pfizer.

Pharmaceutical 130

Pharmaceutical Medical Imaging Medical Clinic 130

AuntMinnie

APRIL 13, 2023

Fusion Pharmaceuticals has secured clearance from the U.S. Read more on AuntMinnie.com Related Reading: Fusion heralds FDA tumor therapy clearance Fusion and Niowave ink $5M collaboration Fusion Pharmaceuticals to build radiopharma plant in Canada Fusion buys radiopharmaceutical from Ipsen Food and Drug Administratio.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals 130

AuntMinnie

JULY 24, 2023

Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitmen.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals 130

Open Medscience

OCTOBER 1, 2024

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

Pharmaceutical 52

Pharmaceutical Quality and Compliance Risk Management Radiopharmaceuticals 52

AuntMinnie

DECEMBER 16, 2024

Carestream Health has secured a distribution contract for its radiology, cardiology, urology, endoscopy, and pharmaceutical offerings with BSF Medical - SARL of Bir El Djir, Algeria. BSF Medical - SARL is one of Algeria's largest medical equipment distributors in both public and private sectors, Carestream said.

Pharmaceutical 130

Pharmaceutical Radiology Medical IT 130

AuntMinnie

SEPTEMBER 12, 2024

In previous smaller studies , zirconium-89 (Zr-89) girentuximab (Zircaix, Telix Pharmaceuticals) PET/CT imaging differentiated ccRC tumors from other kidney tumor types based on its ability to bind to carbonic anhydrase 9 (CAIX), an antigen highly expressed by ccRCC cancer cells.

Pharmaceutical 279

Pharmaceutical Diagnose Imaging Clinic 279

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., subject to its regulatory approval.

Pharmaceutical 147

Pharmaceutical Disease Diagnostic IT 147

AuntMinnie

MARCH 20, 2025

The companies noted that the flexibility of the agreement makes it possible to respond to the needs of pharmaceutical partners at different stages of radiopharmaceutical development and commercialization while addressing regulatory requirements worldwide. AtomVie's new facility is set to open later this year in Hamilton, Ontario, Canada.

Radiopharmaceuticals 130

Radiopharmaceuticals Pharmaceutical IT 130

AuntMinnie

OCTOBER 30, 2024

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 billion in the same period last year.

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

AuntMinnie

JUNE 23, 2023

Radiopharmaceutical developer Actinium Pharmaceuticals is highlighting six researc. Read more on AuntMinnie.com Related Reading: Actinium, Astellas to create actinium-225 radiotherapies Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals 130

AuntMinnie

MARCH 21, 2025

hospitals and pharmaceutical companies and that QP-Prostate was initially cleared in 2021 for automated segmentation of prostate regions. Quibim, based in Valencia, Spain, noted that it recently closed on $50 million in financing to support strategic collaborations with U.S.

Diagnose 130

Diagnose Pharmaceutical Hospital MRI 130

AuntMinnie

JULY 31, 2024

The company’s Pharmaceutical Diagnostics segment generated $639 million in second-quarter revenues, a 14% increase on an organic basis over last year, GE HealthCare reported. Pharmaceutical Diagnostics segment EBIT was $200 million, up 31% over last year. Segment EBIT was $178 million, down 7% from the second quarter of 2023.

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

AuntMinnie

AUGUST 31, 2023

Radiotherapy developer Actinium Pharmaceuticals will present three abstract. Read more on AuntMinnie.com Related Reading: Actinium highlights six abstracts at SNMMI 2023 Actinium, Astellas to create actinium-225 radiotherapies SNMMI 2020: PET tracer could image, treat glioblastoma Zevacor signs on as manufacturing partner for Actinium

Pharmaceutical 130

Pharmaceutical Imaging 130